SMT201600321B - Composizione iniettabile a rilascio graduale antipsicotica - Google Patents

Composizione iniettabile a rilascio graduale antipsicotica

Info

Publication number: SMT201600321B
Authority: SM; San Marino
Prior art keywords: antipsicotica; injectable composition; gradual release; gradual; release
Prior art date: 2010-05-31

Application number

SM201600321T

Other languages

English (en)

Inventor

Ochoa María Teresa Gomez

Aduriz Ibon Gutierro

Original Assignee

Laboratorios Farmacéuticos Rovi S A

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2010-05-31

Filing date

2016-09-15

Publication date

2016-11-10

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=43301889&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT201600321(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2016-09-15 Application filed by Laboratorios Farmacéuticos Rovi S A filed Critical Laboratorios Farmacéuticos Rovi S A

2016-11-10 Publication of SMT201600321B publication Critical patent/SMT201600321B/it

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Dermatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Inorganic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Infusion, Injection, And Reservoir Apparatuses (AREA)

SM201600321T 2010-05-31 2016-09-15 Composizione iniettabile a rilascio graduale antipsicotica SMT201600321B (it)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP10382154.2A EP2394664B1 (en)	2010-05-31	2010-05-31	Antipsychotic injectable depot composition

Publications (1)

Publication Number	Publication Date
SMT201600321B true SMT201600321B (it)	2016-11-10

Family

ID=43301889

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
SM201600321T SMT201600321B (it)	2010-05-31	2016-09-15	Composizione iniettabile a rilascio graduale antipsicotica
SM201600320T SMT201600320B (it)	2010-05-31	2016-09-15	Composizione a deposito iniettabile antipsicotica

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
SM201600320T SMT201600320B (it)	2010-05-31	2016-09-15	Composizione a deposito iniettabile antipsicotica

Country Status (33)

Country	Link
US (2)	US10085936B2 (it)
EP (2)	EP2394664B1 (it)
JP (1)	JP5882993B2 (it)
KR (1)	KR101784330B1 (it)
CN (1)	CN103002917B (it)
AP (1)	AP3524A (it)
AU (1)	AU2011260318B2 (it)
BR (1)	BR112012030686B1 (it)
CA (1)	CA2800111C (it)
CL (1)	CL2012003350A1 (it)
CY (2)	CY1117964T1 (it)
DK (2)	DK2394664T3 (it)
EA (1)	EA024155B1 (it)
ES (2)	ES2589106T3 (it)
HR (2)	HRP20161049T1 (it)
HU (2)	HUE029895T2 (it)
IL (1)	IL223129A (it)
LT (2)	LT2394664T (it)
MA (1)	MA34296B1 (it)
ME (1)	ME02501B (it)
MX (1)	MX338373B (it)
MY (1)	MY161930A (it)
NZ (1)	NZ604342A (it)
PH (1)	PH12012502338B1 (it)
PL (2)	PL2394664T3 (it)
PT (2)	PT2394664T (it)
RS (1)	RS55190B1 (it)
SG (1)	SG185775A1 (it)
SI (2)	SI2394664T1 (it)
SM (2)	SMT201600321B (it)
UA (1)	UA108885C2 (it)
WO (1)	WO2011151355A1 (it)
ZA (1)	ZA201209346B (it)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8852638B2 (en)	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
JP2010531807A (ja)	2007-05-25	2010-09-30	トルマーセラピューティクス，インコーポレイテッド	リスペリドン化合物の徐放送達製剤
US10335366B2 (en)	2010-05-31	2019-07-02	Laboratorios Farmacéuticos Rovi, S.A.	Risperidone or paliperidone implant formulation
US10285936B2 (en)	2010-05-31	2019-05-14	Laboratorios Farmacéuticos Rovi, S.A.	Injectable composition with aromatase inhibitor
US10350159B2 (en) *	2010-05-31	2019-07-16	Laboratories Farmacéuticos Rovi, S.A.	Paliperidone implant formulation
US10881605B2 (en)	2010-05-31	2021-01-05	Laboratorios Farmaceuticos Rovi, S.A.	Methods for the preparation of injectable depot compositions
US10463607B2 (en)	2010-05-31	2019-11-05	Laboratorios Farmaceutics Rofi S.A.	Antipsychotic Injectable Depot Composition
PT2394663T (pt)	2010-05-31	2021-11-26	Farm Rovi Lab Sa	Composições para implantes biodegradáveis injectáveis
HUE029895T2 (en)	2010-05-31	2017-04-28	Farm Rovi Lab Sa	Antipsychotic injectable depot composition
ES2456917T3 (es) *	2011-05-31	2014-04-24	Laboratorios Farmacéuticos Rovi, S.A.	Formulación de implante de paliperidona
PT2529756T (pt) *	2011-05-31	2021-07-28	Farm Rovi Lab Sa	Formulação de implante de risperidona e/ou paliperidona
US20140308352A1 (en)	2013-03-11	2014-10-16	Zogenix Inc.	Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
CN105163719B (zh)	2013-03-11	2019-03-08	度瑞公司	包含高粘度液体载体的可注射控制释放组合物
WO2016199170A2 (en) *	2015-06-10	2016-12-15	Cipla Limited	Paliperidone palmitate particles and compositions thereof
WO2018172850A1 (en)	2017-03-20	2018-09-27	Teva Pharmaceuticals International Gmbh	Sustained release olanzapine formulaitons
CN109589304A (zh) *	2017-10-01	2019-04-09	万特制药(海南)有限公司	利培酮口服溶液及其制备方法
PE20210047A1 (es)	2018-06-12	2021-01-08	Farm Rovi Lab Sa	Composicion inyectable
CN110420212A (zh) *	2019-08-19	2019-11-08	韩自勤	一种用于治疗精神分裂症组合物及其制备方法
US12318387B2 (en)	2021-07-16	2025-06-03	Laboratorios Farmaceuticos Rovi, S.A.	Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition
TW202313047A (zh)	2021-09-21	2023-04-01	西班牙商禾霏藥品實驗室有限公司	抗精神病可注射儲積型組合物
WO2023233051A1 (es)	2022-05-18	2023-12-07	Laboratorios Farmacéuticos Rovi, S.A.	Composiciones inyectables de liberación prolongada para su uso en el tratamiento con risperidona junto a inhibidores de la enzima cyp2d6

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3773919A (en)	1969-10-23	1973-11-20	Du Pont	Polylactide-drug mixtures
BE758156R (fr)	1970-05-13	1971-04-28	Ethicon Inc	Element de suture absorbable et sa
US4389330A (en)	1980-10-06	1983-06-21	Stolle Research And Development Corporation	Microencapsulation process
US4530840A (en)	1982-07-29	1985-07-23	The Stolle Research And Development Corporation	Injectable, long-acting microparticle formulation for the delivery of anti-inflammatory agents
US4523591A (en)	1982-10-22	1985-06-18	Kaplan Donald S	Polymers for injection molding of absorbable surgical devices
US4938763B1 (en)	1988-10-03	1995-07-04	Atrix Lab Inc	Biodegradable in-situ forming implants and method of producing the same
US5620700A (en)	1990-10-30	1997-04-15	Alza Corporation	Injectable drug delivery system and method
US5656297A (en) *	1992-03-12	1997-08-12	Alkermes Controlled Therapeutics, Incorporated	Modulated release from biocompatible polymers
PL314481A1 (en)	1993-11-19	1996-09-16	Janssen Pharmaceutica Nv	Microencapsulated substituted 3-piperidinyl 1,2-benzoisoxazoles and 1,2-benzoisothiazoles
CA2275587C (en)	1996-12-20	2006-10-24	Alza Corporation	Injectable depot gel composition and method of preparing the composition
US6565874B1 (en)	1998-10-28	2003-05-20	Atrix Laboratories	Polymeric delivery formulations of leuprolide with improved efficacy
US6143314A (en)	1998-10-28	2000-11-07	Atrix Laboratories, Inc.	Controlled release liquid delivery compositions with low initial drug burst
US6331317B1 (en) *	1999-11-12	2001-12-18	Alkermes Controlled Therapeutics Ii Inc.	Apparatus and method for preparing microparticles
DE50112157D1 (de) *	2000-01-11	2007-04-19	Roland Bodmeier	Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
US6604561B2 (en) *	2000-02-11	2003-08-12	Medical Instill Technologies, Inc.	Medicament vial having a heat-sealable cap, and apparatus and method for filling the vial
DE60325742D1 (de) *	2002-07-31	2009-02-26	Alza Corp	Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
WO2004064752A2 (en) *	2003-01-22	2004-08-05	Alkermes Controlled Therapeutics, Inc.	Method of preparing sustained release microparticles
US20050003007A1 (en)	2003-07-02	2005-01-06	Michele Boix	Method of sterilization of polymeric microparticles
DK1660039T3 (en) *	2003-07-18	2017-01-16	Oakwood Laboratories L L C	PREVENTION OF REDUCTION OF THE POLYMER MOLECULE WEIGHT, THE PREPARATION OF PURPOSES AND GELING IN POLYMER COMPOSITIONS
US8221778B2 (en)	2005-01-12	2012-07-17	The Trustees Of The University Of Pennsylvania	Drug-containing implants and methods of use thereof
DE102005031868A1 (de) *	2005-07-04	2007-01-18	Biotronik Vi Patent Ag	Arzneimitteldepot zur parenteralen, insbesondere intravaskulären Arzneimittelfreisetzung
US8852638B2 (en) *	2005-09-30	2014-10-07	Durect Corporation	Sustained release small molecule drug formulation
US8076448B2 (en)	2006-10-11	2011-12-13	Tolmar Therapeutics, Inc.	Preparation of biodegradable polyesters with low-burst properties by supercritical fluid extraction
FR2908775B1 (fr) *	2006-11-17	2012-08-31	Biomatlante	Hydrogel et ses applications biomedicales
SI3660073T1 (sl)	2007-02-15	2023-10-30	Tolmar International Limited	Poli (laktid-co-glikolid) z nizkim izpadom
US20080287464A1 (en) *	2007-05-18	2008-11-20	Wright Jeremy C	Depot Formulations
JP2010531807A (ja) *	2007-05-25	2010-09-30	トルマーセラピューティクス，インコーポレイテッド	リスペリドン化合物の徐放送達製剤
AR070033A1 (es) *	2007-11-06	2010-03-10	Panacea Biotec Ltd	Composiciones inyectables, sus procesos y usos
RU2504360C2 (ru) *	2008-08-12	2014-01-20	Новартис Аг	Фармацевтические композиции
US10335366B2 (en)	2010-05-31	2019-07-02	Laboratorios Farmacéuticos Rovi, S.A.	Risperidone or paliperidone implant formulation
US10285936B2 (en)	2010-05-31	2019-05-14	Laboratorios Farmacéuticos Rovi, S.A.	Injectable composition with aromatase inhibitor
US10350159B2 (en)	2010-05-31	2019-07-16	Laboratories Farmacéuticos Rovi, S.A.	Paliperidone implant formulation
PT2394663T (pt)	2010-05-31	2021-11-26	Farm Rovi Lab Sa	Composições para implantes biodegradáveis injectáveis
HUE029895T2 (en)	2010-05-31	2017-04-28	Farm Rovi Lab Sa	Antipsychotic injectable depot composition
PT2529756T (pt)	2011-05-31	2021-07-28	Farm Rovi Lab Sa	Formulação de implante de risperidona e/ou paliperidona
ES2456917T3 (es)	2011-05-31	2014-04-24	Laboratorios Farmacéuticos Rovi, S.A.	Formulación de implante de paliperidona

2010
- 2010-05-31 HU HUE10382154A patent/HUE029895T2/en unknown
- 2010-05-31 LT LTEP10382154.2T patent/LT2394664T/lt unknown
- 2010-05-31 SI SI201031270A patent/SI2394664T1/sl unknown
- 2010-05-31 EP EP10382154.2A patent/EP2394664B1/en active Active
- 2010-05-31 PL PL10382154.2T patent/PL2394664T3/pl unknown
- 2010-05-31 ES ES10382154.2T patent/ES2589106T3/es active Active
- 2010-05-31 DK DK10382154.2T patent/DK2394664T3/en active
- 2010-05-31 PT PT103821542T patent/PT2394664T/pt unknown
2011
- 2011-05-31 CN CN201180026475.2A patent/CN103002917B/zh active Active
- 2011-05-31 MA MA35428A patent/MA34296B1/fr unknown
- 2011-05-31 EA EA201201569A patent/EA024155B1/ru unknown
- 2011-05-31 WO PCT/EP2011/059000 patent/WO2011151355A1/en not_active Ceased
- 2011-05-31 SG SG2012087136A patent/SG185775A1/en unknown
- 2011-05-31 NZ NZ604342A patent/NZ604342A/en unknown
- 2011-05-31 MX MX2012013937A patent/MX338373B/es active IP Right Grant
- 2011-05-31 UA UAA201214486A patent/UA108885C2/ru unknown
- 2011-05-31 PL PL11725383.1T patent/PL2575890T3/pl unknown
- 2011-05-31 KR KR1020127033021A patent/KR101784330B1/ko active Active
- 2011-05-31 RS RS20160730A patent/RS55190B1/sr unknown
- 2011-05-31 EP EP11725383.1A patent/EP2575890B1/en active Active
- 2011-05-31 BR BR112012030686-3A patent/BR112012030686B1/pt active IP Right Grant
- 2011-05-31 JP JP2013512879A patent/JP5882993B2/ja active Active
- 2011-05-31 SI SI201130939A patent/SI2575890T1/sl unknown
- 2011-05-31 AU AU2011260318A patent/AU2011260318B2/en active Active
- 2011-05-31 HU HUE11725383A patent/HUE029056T2/en unknown
- 2011-05-31 AP AP2012006626A patent/AP3524A/xx active
- 2011-05-31 HR HRP20161049TT patent/HRP20161049T1/hr unknown
- 2011-05-31 DK DK11725383.1T patent/DK2575890T3/en active
- 2011-05-31 LT LTEP11725383.1T patent/LT2575890T/lt unknown
- 2011-05-31 ES ES11725383.1T patent/ES2592527T3/es active Active
- 2011-05-31 PH PH1/2012/502338A patent/PH12012502338B1/en unknown
- 2011-05-31 MY MYPI2012701044A patent/MY161930A/en unknown
- 2011-05-31 ME MEP-2016-178A patent/ME02501B/me unknown
- 2011-05-31 PT PT117253831T patent/PT2575890T/pt unknown
- 2011-05-31 CA CA2800111A patent/CA2800111C/en active Active
2012
- 2012-11-19 IL IL223129A patent/IL223129A/en active IP Right Grant
- 2012-11-29 CL CL2012003350A patent/CL2012003350A1/es unknown
- 2012-11-30 US US13/690,647 patent/US10085936B2/en active Active
- 2012-12-10 ZA ZA2012/09346A patent/ZA201209346B/en unknown
2016
- 2016-08-29 HR HRP20161100TT patent/HRP20161100T1/hr unknown
- 2016-08-31 CY CY20161100858T patent/CY1117964T1/el unknown
- 2016-08-31 CY CY20161100857T patent/CY1117969T1/el unknown
- 2016-09-15 SM SM201600321T patent/SMT201600321B/it unknown
- 2016-09-15 SM SM201600320T patent/SMT201600320B/it unknown
2018
- 2018-04-04 US US15/944,894 patent/US10182982B2/en active Active

Also Published As

Publication number	Publication date
CL2012003350A1 (es)	2013-10-18
CN103002917A (zh)	2013-03-27
BR112012030686A2 (pt)	2020-08-25
AP2012006626A0 (en)	2012-12-31
BR112012030686B1 (pt)	2022-11-01
WO2011151355A1 (en)	2011-12-08
AU2011260318A1 (en)	2013-01-10
EP2394664B1 (en)	2016-06-01
RS55190B1 (sr)	2017-01-31
HRP20161100T1 (hr)	2016-11-04
MX2012013937A (es)	2013-02-11
DK2575890T3 (en)	2016-09-12
US10182982B2 (en)	2019-01-22
CA2800111A1 (en)	2011-12-08
US10085936B2 (en)	2018-10-02
PH12012502338B1 (en)	2018-08-31
ES2589106T3 (es)	2016-11-10
LT2575890T (lt)	2016-09-26
KR101784330B1 (ko)	2017-10-11
MA34296B1 (fr)	2013-06-01
PT2575890T (pt)	2016-09-06
CY1117964T1 (el)	2017-05-17
EA024155B1 (ru)	2016-08-31
SMT201600320B (it)	2016-11-10
AP3524A (en)	2016-01-11
PH12012502338A1 (en)	2013-02-11
SI2575890T1 (sl)	2016-10-28
CA2800111C (en)	2018-05-22
US20180221272A1 (en)	2018-08-09
ES2592527T3 (es)	2016-11-30
IL223129A (en)	2016-02-29
PL2575890T3 (pl)	2016-12-30
ZA201209346B (en)	2013-08-28
PT2394664T (pt)	2016-09-06
CY1117969T1 (el)	2017-05-17
AU2011260318B2 (en)	2014-11-27
EP2394664A1 (en)	2011-12-14
EP2575890B1 (en)	2016-06-01
JP2013528612A (ja)	2013-07-11
JP5882993B2 (ja)	2016-03-09
DK2394664T3 (en)	2016-09-12
PL2394664T3 (pl)	2016-12-30
US20130171202A1 (en)	2013-07-04
IL223129A0 (en)	2013-02-03
HRP20161049T1 (hr)	2016-12-30
ME02501B (me)	2017-02-20
EP2575890A1 (en)	2013-04-10
CN103002917B (zh)	2016-04-27
LT2394664T (lt)	2016-09-26
NZ604342A (en)	2014-11-28
HUE029056T2 (en)	2017-02-28
EA201201569A1 (ru)	2013-04-30
SI2394664T1 (sl)	2016-10-28
SG185775A1 (en)	2013-01-30
KR20130118742A (ko)	2013-10-30
MX338373B (es)	2016-04-13
UA108885C2 (uk)	2015-06-25
MY161930A (en)	2017-05-15
HUE029895T2 (en)	2017-04-28

Publication	Publication Date	Title
SMT201600321B (it)	2016-11-10	Composizione iniettabile a rilascio graduale antipsicotica
SMT201600298B (it)	2016-11-10	Derivati n3-sostituiti-n1-solfonil-5- fluoropirimidinone
BR112012031667A2 (pt)	2016-11-08	composição
DK2552261T3 (da)	2019-07-22	Propfilter med proprum med aromakugle
EP2637696A4 (en)	2016-07-06	COMPOSITIONS WITH DELAYED RELEASE
EP2604655A4 (en)	2015-11-11	HARDENING COMPOSITION
EP2598946A4 (en)	2014-05-07	POLYMERIZABLE COMPOSITION
EP2527406A4 (en)	2013-08-14	HARDENING COMPOSITION
EP2530123A4 (en)	2013-09-18	HARDENING COMPOSITION
EP2527399A4 (en)	2014-12-10	POLYESTER RESIN COMPOSITION
EP2644657A4 (en)	2014-04-30	HARDENING COMPOSITION
BR112012032683A2 (pt)	2016-11-29	composição
EP2562196A4 (en)	2016-09-28	HEAT-HARDENING COMPOSITION
FR2969499B3 (fr)	2012-12-14	Auto-injecteurs
EP2530122A4 (en)	2013-09-18	HARDENING COMPOSITION
DE102010034562B8 (de)	2017-08-31	Operationsleuchte mit verbesserter Bedienungsfunktionalität
EP2637493A4 (en)	2015-03-25	Dual mode ratchet pruners
EP2634222A4 (en)	2014-10-15	HARDENING COMPOSITION
EP2636704A4 (en)	2014-05-07	FILM FORMING COMPOSITION
LT2865271T (lt)	2018-12-27	Pagerinta kompozicija
EP2647652A4 (en)	2015-08-26	LIGHT-CURABLE COMPOSITIONS
EP2628769A4 (en)	2014-05-21	FILM FORMING COMPOSITION
BR112012032980A2 (pt)	2016-11-22	composição
DE112010001215A5 (de)	2012-07-05	Gurtaufrollersystem mit einsteuerglied
PL2384901T5 (pl)	2017-10-31	Dokument wartościowy z wybraniem